May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Photothrombosis for Exudative Extrafoveal Polyps in IPCV
Author Affiliations & Notes
  • I. Mantel
    Ophthalmology, Jules, Lausanne, Switzerland
  • A. Ambresin
    Ophthalmology, Jules, Lausanne, Switzerland
  • L. Zografos
    Ophthalmology, Jules, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships  I. Mantel, None; A. Ambresin, None; L. Zografos, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2164. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      I. Mantel, A. Ambresin, L. Zografos; Photothrombosis for Exudative Extrafoveal Polyps in IPCV . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2164.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Treatment for idiopathic polypoidal choroidal vasculopathy (IPCV) is not well established. In cases of exudative changes threatening central vision, conventional thermal laser, PDT and feeder vessel coagulation have been reported to be efficient. In this prospective non–comparative case series we investigate the effect of photocoagulation, enhanced by prior injection of ICG (photothrombosis). The rational is a better uptake of the red dye laser energie through the green ICG in the polyps.

Methods: : A consecutive series of 6 patients (3 male and 3 female) have been treated with photothrombosis for extrafoveal polyps in IPCV, associated with subfoveal exudation and visual loss. Patients were assessed by full ophthalmic examination, angiography with fluorescein and ICG, as well as OCT. They were followed at 1,3,6 and 12 months after treatment, repeating the same examination. They were evaluated for visual acuity, the amount of exudation and the angiographic presence of polyps.

Results: : Mean age was 76 years. All patients but one completed their 12 month visit. At their first follow–up visit, the subretinal fluid was entirely absorbed in 3 cases and significantly reduced in the other 3 cases. All treated polyps had disappeared angiographically. At 12 months, only one patient showed persistant exudation from polyps that were previously hidden under blood. Average visual acuity at baseline was logMAR 0.87 and improved to logMAR 0.52 at the final visit. Three out of 6 patients had significant improvement of their visual acuity by at least 3 lines. Reasons for absent improvement were subfoveal hard exudates in 2 cases and persistant hemorrhagic pigment epithelium detachment in 1 case. We did not observe any treatment related complications.

Conclusions: : Photothrombosis with red dye laser, enhanced by prior injection of ICG appears to be a potentially effective and safe treatment for exudative extrafoveal polyps in IPCV. Functional results however may be limited by subfoveal precipitation of hard exudates or hidden, untreated polyps.

Keywords: age-related macular degeneration • choroid • laser 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.